Perspectives
Drug Pipeline Quarterly Update: December 2020
Drugs in review, drugs with expiring patents, generic availability and more.
December 30, 2020These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.
Related news
Perspectives
June 1, 2023
Prime reimagines patient care, unites care team for a better experience and smarter treatment plan
The patient journey from a cancer diagnosis through treatment with multiple specialty medications…
Perspectives
May 30, 2023
Specialty Drug Pipeline Update: May 2023
This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…
Perspectives
May 30, 2023
Traditional Drug Pipeline Update: May 2023
This monthly pipeline wrap-up provides a review of newly approved traditional drugs, recent…